Predicting Survival Outcomes at Five Years Following Administration of Omega-3 Long-Chain Fatty Acids in People Living with Squamous Cell Carcinoma of the Head and Neck

Vanessa Fuchs Tarlovsky; Obed Sol iacute s Mart iacute nez; Karolina  Aacute lvarez Altamirano; Mar iacute a Dolores Arias Soberon; M oacute nica Patricia Bejarano Rosales; Erika Areli Rosas Gonzalez; Fernand Vedrenne Gutierrez

doi:10.55289/jnutres/v11i2_23.15

Article

VIEWS 3334
PDF 1388

Journal of Nutrition Research

DOI: 10.55289/jnutres/v11i2_23.15

Year: 2023, Volume: 11, Issue: 2, Pages: 69-77

Original Article

Predicting Survival Outcomes at Five Years Following Administration of Omega-3 Long-Chain Fatty Acids in People Living with Squamous Cell Carcinoma of the Head and Neck

Vanessa Fuchs-Tarlovsky ^{✉ 1} , Obed Solís-Martínez ² , Karolina Álvarez-Altamirano ¹ , María Dolores Arias-Soberon ¹ , Mónica Patricia Bejarano-Rosales ¹ , Erika Areli Rosas-Gonzalez ¹ , Fernand Vedrenne-Gutierrez ³

¹ Clinical Nutrition Unit, Hospital General de México, DR Eduardo Liceaga, Mexico City, Mexico

² Instituto Nacional de Salud Pública de México, Mexico City, Mexico

³ Health Sciences Department, Universidad Iberoamericana, Mexico City, Mexico

Corresponding author ✉: [email protected]

Received Date:30 May 2023, Accepted Date:01 July 2023, Published Date:12 August 2023

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

There is a paucity of research on longer-term outcomes following oral nutrition supplementation (ONS) in patients with cancer. An observational analysis on mortality and survival rates were conducted in patients with head and neck squamous cell carcinoma (HNSCC) that received cancer treatment ONS plus 2 g of eicosapentaenoic-acid (EPA) versus standard treatment (EN). Twenty-six participants were available (81.3% of the original cohort [n=32]) in the ONS-EPA 2 g and 24 (75% of original cohort [n=32]) in the ONS-standard groups. Mortality at five years was 50% in the ONS-EPA 2 g and 58.3% in the ONS-standard group but with longer survival time in the ONS-EPA 2 g than the ONS-standard group (35 versus 18 months, respectively). A trend toward a longer survival time five years was observed in participants who received ONS with a high EPA content compared to those who received standard-formula ONS. Results may represent a possible long-term benefit of using high EPA supplementation during active cancer treatment to address malnutrition and positively influence clinical outcomes.

Keywords: Nutritional supplementation, Eicosapentaenoic acid, Head and neck squamous cell carcinoma, 5year mortality

References

Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition. 2017;36(1):11–48. Available from: https://doi.org/10.1016/j.clnu.2016.07.015
Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, et al. ESPEN guideline: Clinical nutrition in surgery. Clinical Nutrition. 2017;36(3):623–650. Available from: https://doi.org/10.1016/j.clnu.2017.02.013
Thompson KL, Elliott L, Fuchs-Tarlovsky V, Levin RM, Voss AC, Piemonte T. Oncology Evidence-Based Nutrition Practice Guideline for Adults. Journal of the Academy of Nutrition and Dietetics. 2017;117(2):297–310. Available from: https://doi.org/10.1016/j.jand.2016.05.010
Gorjao R, Santos CMMD, Serdan TDA, Diniz VLS, Alba-Loureiro TC, Cury-Boaventura MF, et al. New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids. Pharmacology & Therapeutics. 2019;196:117–134. Available from: https://doi.org/10.1016/j.pharmthera.2018.12.001
Shirai Y, Okugawa Y, Hishida A, Ogawa A, Okamoto K, Shintani M, et al. Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia. Scientific Reports. 2017;7(4826):1–9. Available from: https://doi.org/10.1038/s41598-017-05278-0
Murphy RA, Mourtzakis M, Chu QSC, Baracos VE, Reiman T, Mazurak VC. Nutritional intervention with fish oil provides a benefit over standard of care for weight and skeletal muscle mass in patients with nonsmall cell lung cancer receiving chemotherapy. Cancer. 2011;117(8):1775–1782. Available from: https://doi.org/10.1002/cncr.25709
Turcott JG, Juárez-Hernández E, Sánchez-Lara K, Flores-Estrada D, Zatarain-Barrón ZL, Arrieta O. Baseline Dysgeusia in Chemotherapy-Naïve Non-Small Cell Lung Cancer Patients: Association with Nutrition and Quality of Life. Nutrition and Cancer. 2020;72(2):194–201. Available from: https://doi.org/10.1080/01635581.2019.1633362
Blarigan ELV, Fuchs CS, Niedzwiecki D, Ye X, Zhang S, Song M, et al. Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance) Cancer Epidemiology, Biomarkers & Prevention. 2018;27(4):438–445. Available from: https://doi.org/10.1158/1055-9965.EPI-17-0689
Solís-Martínez O, Plasa-Carvalho V, Phillips-Sixtos G, Trujillo-Cabrera Y, Hernández-Cuellar A, Queipo-García GE, et al. Effect of Eicosapentaenoic Acid on Body Composition and Inflammation Markers in Patients with Head and Neck Squamous Cell Cancer from a Public Hospital in Mexico. Nutrition and Cancer. 2018;70(4):663–670. Available from: https://doi.org/10.1080/01635581.2018.1460678
Schueren MAEDVD, Laviano A, Blanchard H, Jourdan M, Arends JM, Baracos VE. Systematic review and meta-analysis of the evidence for oral nutritional intervention on nutritional and clinical outcomes during chemo(radio)therapy: current evidence and guidance for design of future trials. Annals of Oncology. 2018;29(5):1141–1153. Available from: https://doi.org/10.1093/annonc/mdy114
Garlini LM, Alves FD, Ceretta LB, Perry IS, Souza GC, Clausell NO. Phase angle and mortality: a systematic review. European Journal of Clinical Nutrition. 2019;73:495–508. Available from: https://doi.org/10.1038/s41430-018-0159-1
Kumar S, Dutt A, Hemraj S, Bhat S, Manipadybhima B. Phase angle measurement in healthy human subjects through bio-impedance analysis. Iranian Journal of Basic Medical Sciences. 2012;15(6):1180–1184. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646229/pdf/IJBMS-15-1180.pdf
Taha HM, Rozek LS, Chen X, Li Z, Zarins KR, Slade AN, et al. Risk of Disease Recurrence and Mortality Varies by Type of Fat Consumed before Cancer Treatment in a Longitudinal Cohort of Head and Neck Squamous Cell Carcinoma Patients. The Journal of Nutrition. 2022;152(5):1298–1305. Available from: https://doi.org/10.1093/jn/nxac032
Groot RHMd, Emmett R, Meyer BJ. Non-dietary factors associated with 3 long-chain PUFA levels in humans – a systematic literature review. British Journal of Nutrition. 2019;121(7):793–808. Available from: https://doi.org/10.1017/S0007114519000138

Copyright

© This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By India Association for Parenteral and Enteral Nutrition (IAPEN)